Featured Articles

Astellas Pharma Inc. and Seagen Inc. announced that the European Commission (EC) has approved PADCEV (enfortumab vedotin) as monotherapy for the treatment of adult patients with locally…
Read More...

UCB announced it will build an innovative and environmentally sustainable gene therapy process development and clinical manufacturing facility on their high-tech campus in Braine…
Read More...

Novartis announced a license option agreement with Voyager Therapeutics, a gene therapy company focused on next-generation adeno-associated virus (AAV) technologies, for three capsids…
Read More...

Pfizer Inc. announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or RSVpreF, received Breakthrough Therapy Designation from the US Food and Drug…
Read More...

AbbVie announced it has completed the acquisition of Syndesi Therapeutics SA, which will help to expand AbbVie's neuroscience portfolio. This acquisition gives AbbVie access to…
Read More...

Eli Lilly and Company announced the launch of the Lilly Institute for Genetic Medicine and an investment of approximately $700 million to establish a state-of-the-art facility at a new…
Read More...

AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active…
Read More...

Pfizer Inc. and OPKO Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA)…
Read More...

Pfizer Inc. and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, announced they have…
Read More...

Century Therapeutics and Bristol Myers Squibb announced today a research collaboration and license agreement (the “agreement”) to develop and commercialize up to four induced…
Read More...

Amgen and Generate Biomedicines announced a research collaboration agreement to discover and create protein therapeutics for five clinical targets across several therapeutic areas and…
Read More...

Novo Nordisk announced that the acquisition of Dicerna Pharmaceuticals, Inc. announced on 18 November 2021, has been completed. Following the expiration of Novo Nordisk’s cash tender…
Read More...

Merck, a leading science and technology company, announced that it has signed an agreement with biotechnology company Innovative Biotech (IB) to design the manufacturing process for the…
Read More...

Pfizer Inc. and Arena Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Arena, a clinical stage company…
Read More...

Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. for $17.4 billion. "We are very excited to officially welcome our PPD colleagues to Thermo…
Read More...

Sanofi announced it entered into an agreement to acquire Origimm Biotechnology GmbH, an Austrian privately owned biotechnology company specializing in the discovery of virulent skin…
Read More...

Novo Nordisk announced that it has entered into a definitive agreement to acquire Dicerna Pharmaceuticals (Dicerna). The acquisition of Dicerna’s ribonucleic acid interference (RNAi)…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced US government contracts totalling approximately $1 billion (USD) to purchase sotrovimab, an investigational monoclonal antibody…
Read More...

Pfizer Inc. announced an agreement with the U.S. government to supply 10 million treatment courses of its investigational COVID-19 oral antiviral candidate, PAXLOVID™ (PF-07321332;…
Read More...

Amgen announced that it has successfully completed its previously announced acquisition of Teneobio, Inc. (Teneobio). Effective as of Oct. 19, 2021, Amgen has acquired all outstanding…
Read More...